Species Differences inl-Tryptophan–Kynurenine Pathway Metabolism: Quantification of Anthranilic Acid and Its Related Enzymes

Archives of Biochemistry and Biophysics
1998.0

Abstract

Anthranilic acid (AA) has attracted considerable attention as one of the L-tryptophan-kynurenine pathway metabolites in the central nervous system. In this study, a highly sensitive and accurate method for the quantification of AA has been developed using reversed-phase high-performance liquid chromatography with electrochemical detection. Serum and cerebrospinal fluid (CSF) AA concentrations in different animal species were measured. CSF AA concentrations in rabbits were 1.1 +/- 0.1 nmol/liter, which were 5. 7-33.0 times lower than those in other species studied. Serum AA concentrations, however, were slightly higher in rabbits than in other species. In contrast, the concentrations of L-kynurenine (L-KYN) in both serum and CSF were substantially higher in rabbits than in other species. Tissue kynurenine pathway enzymes, indoleamine 2,3-dioxygenase (IDO), tryptophan 2,3-dioxygenase, kynurenine 3-hydroxylase, and kynureninase were determined in rabbits, rats, gerbils, and mice. These enzymes varied among species, especially lung IDO activities in rabbits were 146-516 times higher than those found in other species, but rabbit liver kynurenine 3-hydroxylase activities were lower by one order of magnitude than those of the other species tested. Furthermore, brain kynurenine 3-hydroxylasae activities were 12.3-23.2 times higher in gerbils than those in the other species tested. In addition, AA concentrations in serum following intravenous administration of L-KYN (5 mg/kg) were also measured in rabbits. AA levels peaked sharply within 5 min after administration and decreased in a time-dependent manner. At 5 min after administration, CSF L-KYN and AA concentrations were also increased by 1.76- and 2.56-fold, respectively, compared with basal levels. Increased AA concentrations in CSF following L-KYN administration may reflect the entry of AA into the CSF after conversion to AA in systemic tissue and/or the local synthesis of AA from L-KYN in the CNS.

Knowledge Graph

Similar Paper

Species Differences inl-Tryptophan–Kynurenine Pathway Metabolism: Quantification of Anthranilic Acid and Its Related Enzymes
Archives of Biochemistry and Biophysics 1998.0
Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection
Journal of Chromatography B: Biomedical Sciences and Applications 1996.0
Age-Related Increase of Kynurenic Acid in Human Cerebrospinal Fluid – IgG and β<sub>2</sub>-Microglobulin Changes
Neurosignals 2005.0
Effects of kynurenine metabolites on the electrocorticographic activity in the rat
Journal of Neural Transmission 1998.0
Alternative kynurenic acid synthesis routes studied in the rat cerebellum
Frontiers in Cellular Neuroscience 2015.0
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
Journal of Medicinal Chemistry 2015.0
Crystal Structure of theHomo sapiensKynureninase-3-Hydroxyhippuric Acid Inhibitor Complex: Insights into the Molecular Basis Of Kynureninase Substrate Specificity
Journal of Medicinal Chemistry 2009.0
3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon- γ
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2001.0
Distinct Kynureninase and Hydroxykynureninase Activities in Microorganisms: Occurrence and Properties of a Single Physiologically Discrete Enzyme in Yeast
Journal of Bacteriology 1973.0
Presence and Measurement of Imidazoleacetic Acid, a γ‐Aminobutyric Acid Agonist, in Rat Brain and Human Cerebrospinal Fluid
Journal of Neurochemistry 1989.0